Growing EV Market Izon Science’s focus on extracellular vesicle isolation and characterization aligns with the expanding clinical applications of EVs, presenting significant opportunities to partner with biotech and pharmaceutical companies developing EV-based diagnostics and therapeutics.

Recent Product Launches The launch of the optimized qEV1 columns and Gen 2 series demonstrates continuous innovation, offering sales prospects for laboratories seeking high-throughput, versatile EV isolation solutions.

International Presence With offices in New Zealand, France, and the US, Izon has a global footprint, providing opportunities to market advanced nanotechnology tools across diverse research and clinical markets worldwide.

Collaborative Development Partnerships with biomedical distributors and biotech firms, like Atlantis Bioscience and ABT, highlight potential channels for expanding sales through collaborative product development and joint ventures targeting EV research advancement.

Niche Market Focus Operating in a specialized segment with several small to mid-sized competitors, Izon can capitalize on its innovative, high-resolution nanoparticle analysis tools to differentiate and attract research institutions and early-stage biotech firms looking for precise characterization technologies.